Mutant IDH1 and IDH2 undergo a conformational change resulting in enzymatic activity which converts α-ketoglutarate to its structural derivative 2-hydroxyglutarate which has been found at high concentrations in mutant gliomas (232, 233). This evidence concerns the gene IDH2 and central nervous system cancer.